Jp. Shenai et al., SEQUENTIAL EVALUATION OF PLASMA RETINOL-BINDING PROTEIN RESPONSE TO VITAMIN-A ADMINISTRATION IN VERY-LOW-BIRTH-WEIGHT NEONATES, Biochemical and molecular medicine, 54(1), 1995, pp. 67-74
Vitamin A (retinol) deficiency is associated with impaired healing fro
m lung injury in very-low-birthweight (VLBW) neonates susceptible to b
ronchopulmonary dysplasia (BPD). Vitamin A supplementation from birth
may ameliorate this adverse outcome, We hypothesized that plasma retin
ol-binding protein (REP) response to vitamin A administration, which p
rovides a dynamic measure of vitamin A status, might be useful for ear
ly recognition of vitamin A deficiency in VLBW neonates at risk for BP
D. We prospectively studied 20 VLBW neonates (inclusion criteria: birt
h weight <1300 g, gestational age <30 weeks, need for supplemental oxy
gen and mechanical ventilation for >24 h after birth) who were eligibl
e to receive vitamin A supplementation. In addition to sequential asse
ssment of;vitamin A status, we measured plasma REP just before and 3 a
nd 6 h after an intramuscular injection of vitamin A (2000 IU/kg retin
yl palmitate) on Postnatal Days 1, 7, 15, 21, 29, and 43. The percenta
ge increase in plasma REP (Delta-RBP) was calculated. A high plasma De
lta-RBP value (>8%) is indicative of vitamin A deficiency. Based on pu
lmonary outcome, the infants were divided into two groups: BPD (n = 12
) and No BPD (n = 8). Mean vitamin A intake ranged from 1414 to 2114 I
U/kg/day and did not differ between infant groups. Mean plasma vitamin
A concentration increased from baseline levels on Postnatal Day 1 to
levels within the desired range of 1.05-2.10 mu mol/liter (30.0-60.0 m
u g/dl) during supplementation period in both infant groups. Infants w
ith BPD, in contrast to those without BPD, had worsening plasma Delta-
RBP values from Postnatal Day 15, indicative of persistence of vitamin
A deficiency despite supplementation and normalization of plasma vita
min A concentration. We conclude that plasma REP response to vitamin A
administration is useful for early recognition of vitamin A deficienc
y in VLBW neonates at risk for BPD. (C) 1995 Academic Press, Inc.